首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1441338

全球表觀遺傳學市場規模、佔有率、成長分析、依產品類型（試劑、試劑盒）、依技術（DNA 甲基化、組蛋白甲基化）、依應用（腫瘤、心血管疾病）- 2023- 2030 年產業預測

Global Epigenetics Market Size, Share, Growth Analysis, By Product type(Reagents, Kits), By Technology(DNA Methylation, Histone Methylation), By Application(Oncology, Cardiovascular Diseases) - Industry Forecast 2023-2030

出版日期: 2024年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球表觀遺傳學市場規模為13.6億美元，預計將從2023年的16億美元成長到2031年的47億美元，在預測期內（2024-2031年）複合CAGR為14.8%。

由於基因組研究的進步和對錶觀遺傳學機制的更深入理解，全球表觀遺傳學市場正在經歷顯著成長，促使近年來全球表觀遺傳學行業消費者偏好和需求的變化。表觀遺傳學是在不改變潛在 DNA 序列的情況下對基因活性的可遺傳修飾進行研究，它對於許多生物過程和疾病都很重要。神經病學、心臟病學、腫瘤學和其他治療領域不斷成長的應用正在推動市場發展。表觀遺傳學的三個主要研究領域包括非編碼 RNA 調控、組蛋白修飾和 DNA 甲基化。由於對標靶藥物和個人化醫療的需求不斷成長，表觀遺傳學市場預計將進一步成長。為了帶來尖端技術和解決方案，該行業的主要參與者都在研發上投入資金，這有助於全球表觀遺傳學市場的整體成長和發展。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

AbbVie Inc.
AstraZeneca PLC
Bayer AG
BeiGene Ltd.
Bristol Myers Squibb Company
Epizyme, Inc.
GlaxoSmithKline PLC
Incyte Corporation
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Roche Holding AG
Seattle Genetics, Inc.
Takeda Pharmaceutical Company Limited
Targovax, Inc.
Vertex Pharmaceuticals Incorporated
Vivid Biosciences Inc.
Zymeworks Inc.

簡介目錄

Product Code: SQMIG35H2201

Global Epigenetics Market size was valued at USD 1.36 billion in 2022 and is poised to grow from USD 1.6 billion in 2023 to USD 4.7 billion by 2031, growing at a CAGR of 14.8% during the forecast period (2024-2031).

The Global Epigenetics Market is experiencing significant growth due to the advances in genomic research and a greater comprehension of epigenetic mechanisms, leading to changes in consumer preferences and needs in the worldwide epigenetics industry in recent years. Epigenetics is the study of heritable modifications to gene activity without changing the underlying DNA sequence, and it is important for many biological processes and disorders. Growing applications in neurology, cardiology, oncology, and other therapeutic areas are driving the market. Three main areas of study in epigenetics include non-coding RNA regulation, histone modification, and DNA methylation. The market for epigenetics is anticipated to grow further due to the growing need for targeted medicines and personalized medicine. In order to bring cutting-edge technology and solutions, major players in the business are spending in research and development, which helps the overall growth and evolution of the global epigenetics market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Epigenetics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Epigenetics Market Segmental Analysis

There are four main segments in the worldwide Epigenetics Market: product type, technology, application, and region. It is separated into reagents, kits, instruments, enzymes, and services according to kind. It is divided into two categories according to technology: additional epigenetic alterations and microRNA modification, and histone acetylation, DNA methylation, and histone methylation. It is divided into categories according to application, including immunology, neurological disorders, metabolic diseases, cardiovascular diseases, and oncology. The market is divided into North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa based on geographic factors.

Drivers of the Global Epigenetics Market

A major driver in this market is growing understanding of how essential epigenetic mechanisms are for controlling gene expression and affecting a range of biological functions. The demand for epigenetic tools and technologies has increased due to this increased understanding, which has spurred a boom in research activity across the academic, pharmaceutical, and biotechnology sectors. Furthermore, there is a greater emphasis on customized medicine due to the increased prevalence of chronic illnesses like cancer and neurological disorders, where epigenetics is essential in determining the best course of treatment.

Restraints in the Global Epigenetics Market

The high cost of advanced epigenetic technologies is one of the primary market barriers, preventing wider acceptance and accessibility, especially in areas with limited resources. The regulatory hurdles posed by ethical considerations and data privacy issues in epigenetic research have an impact on the rate of innovation. In addition, challenges to a smooth incorporation into clinical practice include the difficulty of interpreting epigenetic data and the absence of standardized analytical techniques..

Market Trends of the Global Epigenetics Market

The growing use of epigenetic insights in customized medicine is propelling the creation of specific treatments for a range of illnesses. Research activities are becoming more precise and efficient as a result of the integration of artificial intelligence and machine learning in the processing of large epigenomic datasets. Furthermore, non-invasive epigenetic diagnostics-which use tools like liquid biopsies to detect diseases like cancer early-are receiving more attention. With the increasing popularity of epigenome editing tools, researchers can now alter particular epigenetic marks, creating new opportunities for therapeutic interventions.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Epigenetics Market by Product type

Market Overview
Reagents
Kits
Instruments
Enzymes
Services

Global Epigenetics Market by Technology

Market Overview
DNA Methylation
Histone Methylation
Histone Acetylation
MicroRNA Modification
and Other Epigenetic Modifications

Global Epigenetics Market by Application

Market Overview
Oncology
Cardiovascular Diseases
Metabolic Diseases
Neurological Disorders
Immunology

Global Epigenetics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BeiGene Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epizyme, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Incyte Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seattle Genetics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Targovax, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivid Biosciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zymeworks Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments